1. Home
  2. ARTV vs AAME Comparison

ARTV vs AAME Comparison

Compare ARTV & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • AAME
  • Stock Information
  • Founded
  • ARTV 2019
  • AAME 1968
  • Country
  • ARTV United States
  • AAME United States
  • Employees
  • ARTV N/A
  • AAME N/A
  • Industry
  • ARTV
  • AAME Life Insurance
  • Sector
  • ARTV
  • AAME Finance
  • Exchange
  • ARTV NYSE
  • AAME Nasdaq
  • Market Cap
  • ARTV 39.0M
  • AAME 35.9M
  • IPO Year
  • ARTV 2024
  • AAME N/A
  • Fundamental
  • Price
  • ARTV $1.61
  • AAME $2.34
  • Analyst Decision
  • ARTV Strong Buy
  • AAME
  • Analyst Count
  • ARTV 8
  • AAME 0
  • Target Price
  • ARTV $18.14
  • AAME N/A
  • AVG Volume (30 Days)
  • ARTV 303.9K
  • AAME 22.4K
  • Earning Date
  • ARTV 08-28-2025
  • AAME 08-13-2025
  • Dividend Yield
  • ARTV N/A
  • AAME 0.85%
  • EPS Growth
  • ARTV N/A
  • AAME N/A
  • EPS
  • ARTV N/A
  • AAME N/A
  • Revenue
  • ARTV N/A
  • AAME $191,355,000.00
  • Revenue This Year
  • ARTV N/A
  • AAME N/A
  • Revenue Next Year
  • ARTV N/A
  • AAME N/A
  • P/E Ratio
  • ARTV N/A
  • AAME N/A
  • Revenue Growth
  • ARTV N/A
  • AAME 2.04
  • 52 Week Low
  • ARTV $1.47
  • AAME $1.25
  • 52 Week High
  • ARTV $17.31
  • AAME $2.61
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • AAME 83.26
  • Support Level
  • ARTV N/A
  • AAME $1.94
  • Resistance Level
  • ARTV N/A
  • AAME $2.61
  • Average True Range (ATR)
  • ARTV 0.00
  • AAME 0.16
  • MACD
  • ARTV 0.00
  • AAME 0.05
  • Stochastic Oscillator
  • ARTV 0.00
  • AAME 81.40

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

Share on Social Networks: